Cleared Traditional

K861924 - MICRO ANASTOMOSIS CLAMP

K861924 is an FDA 510(k) clearance for MICRO ANASTOMOSIS CLAMP, manufactured by Pilling Co.. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Traditional 510(k) pathway after a 18-day FDA review.

K861924 · Pilling Co. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1986
Decision
18d
Days
Class 2
Risk

K861924 is an FDA 510(k) clearance for the MICRO ANASTOMOSIS CLAMP. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Pilling Co. (Fort Washington, US). The FDA issued a Cleared decision on June 6, 1986 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pilling Co. devices

FDA 510(k) Submission Details - K861924

510(k) Number K861924 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 1986
Decision Date June 06, 1986
Days to Decision 18 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
107d faster than avg
Panel avg: 125d · This submission: 18d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 100
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K861924.
PTI INTRA-ART(TM) CORONARY ARTERY OCCLUDERS (STER)
K882879 · Pioneering Technologies, Inc. · Sep 1988
VASCULAR CLAMP
K881158 · T. Korossurgical Instruments Corp. · Jun 1988
AUTO SUTURE DISPOSABLE APPROXIMATING CLAMP*
K875090 · United States Surgical, A Division of Tyco Healthc · Feb 1988
FOGARTY 6MM SOFTJAW CLIP
K832554 · American Edwards Laboratories · Sep 1983
P-S BERLIN VESSEL CLAMP
K820949 · Pudenz-Schulte Medical Research Corp. · Apr 1982
VASCULAR PAWS
K813062 · Sil-Med Corp. · Dec 1981